Monoclonal antibodies to human breast carcinoma cells and their use in diagnosis and therapy
CA 1215331 A · Owner: Health Research, Inc. (Roswell Park Division) · Inventors: Chu, Tsann M.; Papsidero, Lawrence D.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Monoclonal antibodies to adenocarcinoma cells and, in particular, breast carcinoma cells are produced, by a hybridoma formed by fusing mouse lymphocytes and mouse myeloma cells. The monoclonal antibodies are capable of shrinking solid tumors associated with human breast. The monoclonal antibodies, specifically F36/22, monoclonal antibodies, can be used diagnostically and therapeutically.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted December 16, 1986. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended December 16, 2003.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.